Segment disclosures

Company overview

Jazz Pharmaceuticals plc

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 1 retained observations 1 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Luvox Cr Revenue Recognition Timing Change

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=jazz:LuvoxCrRevenueRecognitionTimingChangeMember
PeriodValueUnitFiledEvidence
2010-10-01 – 2010-12-312000000 USD20120228Open filing evidence